Gene · 80310
Papers1,555
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 1,555
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Perspectives on miRNAs as Epigenetic Markers in Osteoporosis and Bone Fracture Risk: A Step Forward in Personalized Diagnosis. | Front Genet | 2019 | 31737038 | PubTator, text mining | PubMed |
| Improved Biomarker and Imaging Analysis for Characterizing Progressive Cardiac Fibrosis in a Mouse Model of Chronic Chagasic Cardiomyopathy. | J Am Heart Assoc | 2019 | 31718442 | PubTator, text mining | PubMed |
| Association between ADAMTS7 polymorphism and carotid artery plaque vulnerability. | Medicine (Baltimore) | 2019 | 31651847 | PubTator, text mining | PubMed |
| Elevated preoperative platelet distribution width predicts poor prognosis in Esophageal Squamous Cell Carcinoma. | Sci Rep | 2019 | 31645619 | PubTator, text mining | PubMed |
| Comprehensive analysis of the lncRNA‑associated competing endogenous RNA network in breast cancer. | Oncol Rep | 2019 | 31638237 | PubTator, text mining | PubMed |
| DNA methylation detection methods used in colorectal cancer. | World J Clin Cases | 2019 | 31624740 | PubTator, text mining | PubMed |
| Platelets and Hepatocellular Cancer: Bridging the Bench to the Clinics. | Cancers (Basel) | 2019 | 31618961 | PubTator, text mining | PubMed |
| Cancer-related long noncoding RNAs show aberrant expression profiles and competing endogenous RNA potential in esophageal adenocarcinoma. | Oncol Lett | 2019 | 31611990 | PubTator, text mining | PubMed |
| Platelet-derived growth factor-BB promotes proliferation and migration of retinal microvascular pericytes by up-regulating the expression of C-X-C chemokine receptor types 4. | Exp Ther Med | 2019 | 31611940 | PubTator, text mining | PubMed |
| DNA methylome-wide alterations associated with estrogen receptor-dependent effects of bisphenols in breast cancer. | Clin Epigenetics | 2019 | 31601247 | PubTator, text mining | PubMed |
| Resolving the fibrotic niche of human liver cirrhosis at single-cell level. | Nature | 2019 | 31597160 | PubTator, text mining | PubMed |
| Intermittent compressive force promotes osteogenic differentiation in human periodontal ligament cells by regulating the transforming growth factor-β pathway. | Cell Death Dis | 2019 | 31591384 | PubTator, text mining | PubMed |
| The Difference of Expression of 18 Genes in Axillary Invasion and Vascular Invasion Compared to Control Samples in Breast Cancer. | Iran J Pathol | 2019 | 31582999 | PubTator, text mining | PubMed |
| Mitogen-Activated Protein Kinases (MAPKs) and Cholangiocarcinoma: The Missing Link. | Cells | 2019 | 31569444 | PubTator, text mining | PubMed |
| Enhancement of therapeutic potential of mesenchymal stem cell-derived extracellular vesicles. | Stem Cell Res Ther | 2019 | 31547882 | PubTator, text mining | PubMed |
| An oncogenic activity of PDGF-C and its splice variant in human breast cancer. | Growth Factors | 2019 | 31542979 | PubTator, text mining | PubMed |
| Crucial lncRNAs associated with adipocyte differentiation from human adipose-derived stem cells based on co-expression and ceRNA network analyses. | PeerJ | 2019 | 31534842 | PubTator, text mining | PubMed |
| Cell surface-anchored serine proteases in cancer progression and metastasis. | Cancer Metastasis Rev | 2019 | 31529338 | PubTator, text mining | PubMed |
| Dermatofibrosarcoma Protuberans of the Breast in Man: An Extremely Rare Entity With a Review of the Literature. | J Investig Med High Impact Case Rep | 2019 | 31522558 | PubTator, text mining | PubMed |
| Estrogen receptors promote NSCLC progression by modulating the membrane receptor signaling network: a systems biology perspective. | J Transl Med | 2019 | 31511014 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/80310/papers?page=38